This publication highlights our work on intelligent drug discovery using hybrid neural computing devices. NEUREKA’s innovative system combines living neurons with a simulated network, offering a more realistic environment for testing potential drugs. This is a significant step forward for NEUREKA, and we’re grateful for the opportunity to share our findings with a wider audience.